Dr. Desong Yang 杨德松
Chief Physician
Department of Thoracic Surgery I, Hunan Cancer Hospital, Changsha
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical treatment of lung cancer, esophageal cancer, and mediastinal tumors using open and minimally invasive techniques. Specializes in complex thoracic surgeries, including total thoracoscopic bronchial sleeve resection and pulmonary artery reconstruction lobectomy, as well as difficult EBUS-TBNA procedures.
Dr. Yang holds a doctorate in surgery from Peking University Health Science Center and serves as Chief Physician in the Department of Thoracic Surgery II at Hunan Cancer Hospital. Research focuses on minimally invasive diagnosis and treatment of thoracic diseases, with in-depth study of early diagnosis and management of solitary pulmonary nodules and multiple ground-glass opacities.
Professional roles
- Vice Chair, Youth Committee of the Thoracic Surgery Professional Committee, Hunan Medical Association
- National Member, Thoracoscopy Professional Committee, Endoscopic Physicians Branch, Chinese Medical Doctor Association
- National Member, Thoracic Surgery Professional Committee, Chinese Research Hospital Association
Name order: in Chinese the family name comes first (Yang Desong). Papers usually list the name as Desong Yang or Yang D.
Selected publications
42 papers on PubMed matched by name and affiliation; 7 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Thorac Dis, 2026 (senior author): Efficacy and safety of neoadjuvant targeted therapy in surgically treated patients with ALK-rearranged non-small cell lung cancer. PubMed 42865815
- Am J Respir Crit Care Med, 2026 (senior author): Biological heterogeneity and biomarker-driven personalization: advancing mesenchymal stromal cell therapy for ARDS. PubMed 41091102
- Front Immunol, 2026 (senior author): Survival benefit and dynamics of CD8(+) T cells and tumor-associated macrophages in neoadjuvant immunochemotherapy vs. chemotherapy for locally advanced esophageal squamous cell carcinoma: an IPTW-adjusted real-world study. PubMed 41972149
- Medicine (Baltimore), 2025 (first author): Distinguishing MPLCs from IPMs using NGS-based molecular algorithms and histological assessment: A systematic review and validation study. PubMed 39993063
- Lung Cancer, 2024 (senior author): Efficacy and safety of pralsetinib in patients with RET fusion positive non-small cell lung cancer: An observational real world study. PubMed 39241296
- J Int Med Res, 2021 (first author): Next-generation sequencing revealed synchronous double primary lung squamous carcinoma: a case report. PubMed 34038210
- J Thorac Dis, 2018 (first author): Total thoracoscopic high-position sleeve lobectomy of the right upper lobe of the lung. PubMed 30174901
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion